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Daptomycin is the first member of the class of cyclic lipopeptide antibiotic drugs with a broad spectrum of activity against
Gram-positive bacteria [1]. The outcome of a therapy with daptomycin in clinical practice is comparable with standard
antibiotic treatment and has a linear pharmacokinetics in healthy volunteers with a plasma half-life of about 9h, with drug
excretion via kidneys [2]. However, daptomycin shows additional activity against multi-resistant bacterial strains like
methicillin-resistant Staphylococcus aureus (MRSA) [3], vancomycin-resistant enterococci (VRE) [4] or penicillin-resistant
Streptococcus pneumoniae [5] and it is therefore a viable alternative for the treatment of persisting infections. Standard
doses ranged from 4 to 6 mg/kg, in several cases physicians are prescribing higher dosages up to 10 or 12 mg/kg [6]. Its
efficacy and safety has been evaluated in a variety of infectious conditions, especially in critical care settings. Some factors
may influence daptomycin PK and its PK/PD, especially in hospitalized patients (CKD, GFR < 30 ml/min) [7]. Therefore,
therapeutic drug monitoring protocols are highly recommended and they can be performed by high performance liquid
chromatography (HPLC) systems. Literature and guidelines recommend therapeutic doses for daptomycin [8] to avoid side
effects, such as renal failure, hepatotoxicity and rhabdomyolysis [9-10].
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Application of a new HPLC-UV method on 122 plasma samples of patients from
various AOUP wards, after analytical method settings, validation and comparison with
a reference LC-MS/MS method. All research activities were performed according to
the “Daptolin” protocol (approved by the Pisa University Hospital Ethics Committee,
prot. num. 55945)
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INSTRUMENTS: The HPLC-UV method was developed using a Waters Alliance 2695
Separations Module equipped with a Waters 2487 Dual l Absorbance Detector
(Waters Corporation, Milford, CT) and controlled by the Empower software (version
Pro, Waters Corporation).
The LC-MS/MS kit was applied using a Acquity UPLC Binary Solvent Manager pump
with Sample Manager autosampler equipped with a TQ Detector (Waters
Corporation,). LC-MS/MS system was controlled by MassLynx software (version V4.1,
Waters Corporation, USA).
CALIBRATION AND QUALITY CONTROL SAMPLES: A daptomycin stock solution was
prepared by dissolving 10 mg of daptomycin in 10 ml of water (final concentration,
1000 mg/l). From this stock solution, 100 µl was diluted with 900 µl of blank human
plasma (obtained from healthy volunteers), obtaining a working solution of 100 mg/l.
A gentamicin stock solution was prepared diluting 10 µl of gentamicin 40 mg/ml in 1
ml of water (final concentration 400 mg/l). From this solution, 100 µl were diluted in
900 µl of blank human plasma from healthy volunteers, obtaining a working solution
of 40 mg/l.
SAMPLE PREPARATION Protein precipitation = 20 µl of gentamicin 100 mg/l such
Internal Standard, were added to at 200 µl of plasma sample. After vortexing for 30
sec, plasma proteins were precipitated by additing organic solvent. Different tests:
Acetonitrile, Methanol, Acetonitrile + H3PO4 conc. 5% (v/v).
HPLC-UV SETTINGS: The HPLC mobile phase consisted of organic solvent (i.e., ACN
and/or MeOH) plus buffer KH2PO4 20 mM pH=3.2. The choice of final pH was
dependent on the chemical structure of daptomycin and gentamycin in order to
optimize the interaction of analytes with stationary phase. Stationary phase: Higgins
Analytical C18 5 µm (250 mm x 4.6 mm) at 35 °C.
Flow: 1,0 ml/min; Injection volume: 50 µl; UV Wavelenght: 262 nm
LC-MS/MS ANALYSIS: plasma samples analyzed by using a commercial kit (Eureka –
Lab Division) for LC/MS.
VALIDATION STUDIES [11]:
Linearity range concentrations: daptomycin and gentamicin 5, 10, 25, 50, 100 mg/l;
Precision intra-day: 2(1-0.5logConc)´2/3; Inter-day: 2(1-0.5logConc)
Specificity was evaluate analyzing interfering peaks at the same retention times of
daptomycin and gentamicin. LOD: signal-to-noise ratio ≥ 3 LOQ: 3.04 x LOD
SAMPLES: From November 2018 to February 2019, 122 plasma samples from AOUP
Pisa Hospital wards (Infectious diseases, cardiovascular diseases, orthopaedics,
general medicine and neurosurgery) were analyzed.
STATISTICAL ANALYSIS: The software Graph Pad Prism 7 (Graph Pad Software®, USA)
was used. Correlation analyses were done between daptomycin concentrations of
HPLC-UV data and LC-MS/MS reference method. Level of significance was set at
p<0.05.
Instruments, samples and methods
The better recovery after sample analytes extraction was obtained by using ACN -
H3PO4 85% (95:5 v/v) (Table 1). The mobile phase was chosen on the basis of
retention time values and optimal separation, which were achieved by ACN-buffer
KH2PO4 20 mM pH=3.2 46:54, v/v. Retention times were 4.1 and 5.6 min for
daptomycin and gentamicin, respectively (Figures 1 and 2). Tables 2 and 3 report the
complete list of analytical parameters for method validation.
The performance of the present method was compared with a commercial LC-MS/MS
method on 122 human plasma samples. The correlation analysis of measured plasma
concentrations returned an r2 value of 0.9474, a slope of 1.052 and a y-intercept of
0.8543 ± 0.9368 mg/L (Figure 3), without significant differences between the two
methods (Mann-Whitney and unpaired t-test with Welch’s correction, p=1.000 and
0.9927, respectively).
Results
In conclusion, a reliable and rapid HPLC-UV method was validated to measure
daptomycin concentrations in plasma samples using an internal standard for
better accuracy and precision over the range of drug concentrations expected
after the administration of daptomycin at standard doses. Furthermore, to our
knowledge, this is the first HPLC-UV method for daptomycin that has been
compared with a LC-MS/MS reference method. Moreover, the simple
preanalytical preparation of samples and the reduced costs of HPLC platform
certainly ensure a wide diffusion of the present method, optimal for routine in
laboratory. For these reasons, the method is currently used to monitor all plasma
samples dispatched to our Clinical Pharmacology Unit.
Conclusions
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Figure 1. Analytes RT at different mobile phases 
Solvents Rec %(mean ± SD, n = 10)
ACN - H3PO4
85% 
(95:5 v/v)
98.2 ± 4.57
ACN 85.1 ± 5.47
CH3OH 70.6 ± 3.67
TCA 10 % 45.9 ± 4.65
Table 1. Solvent for extraction
Concentration (mg/L) Accuracy (%) Precision (%) CV%DAY Theoretical Measured
1
5 4.77 ± 0.70 4.64 0.88 14.61
50 49.32 ± 2.26 2.20 0.20 0.00
100 98.29 ± 2.78 1.71 0.05 2.83
2
5 4.77 ± 0.69 4.58 0.88 14.39
50 48.80 ± 2.26 2.40 0.21 4.64
100 97.76 ± 3.99 2.24 0.01 4.08
3
5 4.62 ± 0.46 1.41 0.87 0.00
50 50.41 ± 3.34 -0.81 0.20 6.62
100 99.75 ± 0.76 0.25 0.001 0.77
Concentration (mg/L) Acc. 
(%)
Prec.
(%) CV%
LOD 
(mg/L)
LOQ 
(mg/L) r
2
Theoretical Measured
5 4.77 ± 0.83 3.19 1.32 11.65
1.26 3.85
0.9975 ±
0.0009
50 49.74 ± 2.39 0.53 0.30 4.80
100 98.60 ± 2.86 1.40 0.01 2.90
Table 2. Inter-day parameters
Contacts
Table 3. Intra-day parameters
Figure 2. HPLC-UV chromatogram of 
plasma extracted samples:
Peaks:
• Daptomycin 4,10 min
• Gentamicin 5,60 min (Internal Standard)
Linear correlation of daptomycin
concentration values obtained with HPLC-UV
and LC-MS/MS methods in 122 plasma
samples. The linear correlation analysis
returned a r2 value of 0.9474 (p < 0.0001 ),
slope of 1.052 and y-intercept of 0.8543 ±
0.9368 mg/l. Linear regression line is
perfectly included within the 95% confidence
interval.
Figure 3. Linear correlation HPLC-UV and LC-
MS/MS
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